Lab Hra Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LAB HRA PHARMA, and when can generic versions of LAB HRA PHARMA drugs launch?
LAB HRA PHARMA has one approved drug.
There are eight US patents protecting LAB HRA PHARMA drugs.
There are fifty-five patent family members on LAB HRA PHARMA drugs in twenty-eight countries.
Drugs and US Patents for Lab Hra Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 10,159,681 | ⤷ Subscribe | ⤷ Subscribe | |||
Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 10,772,897 | ⤷ Subscribe | ⤷ Subscribe | |||
Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 8,426,392 | ⤷ Subscribe | ⤷ Subscribe | |||
Lab Hra Pharma | ELLA | ulipristal acetate | TABLET;ORAL | 022474-001 | Aug 13, 2010 | AB | RX | Yes | Yes | 9,844,510 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LAB HRA PHARMA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 30 mg | ➤ Subscribe | 2014-08-13 |
International Patents for Lab Hra Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Hungary | E029434 | ⤷ Subscribe |
South Africa | 201104137 | ⤷ Subscribe |
New Zealand | 593498 | ⤷ Subscribe |
Colombia | 6400186 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.